$65.670
-1.799 (-2.74%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TVTX Prediction & Forecast by Similar Chart Analysis
Alphio's TVTX stock price prediction model matches the current Travere Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $65.46 (-0.32%). The 1-week path is $62.54 (-4.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Travere Therapeutics Inc Stock?
Travere Therapeutics Inc is a good buy right now due to its strong revenue growth of 48% year-over-year in Q2 2026, reaching $169 million, and a solid gross margin of 96.45%. The stock has a favorable analyst price target range of $75 to $78, suggesting a potential upside of 14% to 19% from the current price. However, the main risk is the significant net loss of $34.79 million reported for Q2 2026, which indicates ongoing financial challenges that could affect future performance.
TVTX stock price ended at $65.67 on Friday, after losing -2.74%
Travere Therapeutics Inc (TVTX) last closed at $65.67, losing -2.74%. These facts feed the 1-day and 1-week TVTX price prediction above.
Forecast Drivers
Travere Therapeutics Inc (TVTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TVTX, ranked by similarity.
Seasonality analysis for TVTX
Historically the probability of a positive August return for TVTX is 31.75%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TVTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $20.89 | $24.65 | $30.49 | -62.46% |
| Sep 2026 | $16.39 | $23.58 | $29.09 | -64.10% |
| Oct 2026 | $26.19 | $28.89 | $34.13 | -56.01% |
| Nov 2026 | $18.78 | $21.70 | $29.21 | -66.95% |
| Dec 2026 | $17.95 | $22.30 | $24.24 | -66.04% |
In 2026, Travere Therapeutics Inc (TVTX) is projected to range from $16.39 to $34.13.
Travere Therapeutics Inc 2026 monthly forecast
In Aug 2026, Travere Therapeutics Inc is projected to average $24.65, with a low of $20.89 and high of $30.49.
In Sep 2026, Travere Therapeutics Inc is projected to average $23.58, with a low of $16.39 and high of $29.09.
In Oct 2026, Travere Therapeutics Inc is projected to average $28.89, with a low of $26.19 and high of $34.13.
In Nov 2026, Travere Therapeutics Inc is projected to average $21.70, with a low of $18.78 and high of $29.21.
In Dec 2026, Travere Therapeutics Inc is projected to average $22.30, with a low of $17.95 and high of $24.24.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.